APA (7th ed.) Citation

Bosch-Barrera, J., Bosch-Barrera, J., Bosch-Barrera, J., Sais, E., Sais, E., Sais, E., . . . Menendez, J. A. (2025). The STAT3/TIMP1 inhibitor silibinin overcomes secondary immunoresistance to pembrolizumab in brain metastases from METex14 skipping mutated non-small cell lung cancer: A case report. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Bosch-Barrera, Joaquim, et al. The STAT3/TIMP1 Inhibitor Silibinin Overcomes Secondary Immunoresistance to Pembrolizumab in Brain Metastases from METex14 Skipping Mutated Non-small Cell Lung Cancer: A Case Report. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Bosch-Barrera, Joaquim, et al. The STAT3/TIMP1 Inhibitor Silibinin Overcomes Secondary Immunoresistance to Pembrolizumab in Brain Metastases from METex14 Skipping Mutated Non-small Cell Lung Cancer: A Case Report. Frontiers Media S.A, 2025.